Liberty Hospital has been awarded national accreditation by the American College of Surgeons’ Commission on Cancer (CoC) for delivering high-quality, multidisciplinary, patient-centered care to cancer patients.
“This important designation reflects our collaboration with Saint Luke’s Cancer Institute and other practitioners to deliver personalized, leading-edge care to our community,” interim hospital president and CEO Raghu Adiga, MD, said. “We appreciate the commitment of our physicians, hospital and clinic team to set and attain high standards and achieve this outstanding accomplishment.”
Since 2015 Liberty Hospital and Saint Luke’s Cancer Institute have partnered to provide a comprehensive diagnostic and treatment program that offers personalized options for patients at every stage of their cancer journey. The program includes multidisciplinary treatment planning as well as access to industry and National Cancer Institute (NCI)-sponsored studies. It provides precision oncology services, a leading-edge breast care program and genetic counseling as well as on-site infusion and chemotherapy, rehabilitation, survivorship and support services.
Members of the hospital’s Cancer Committee represent Liberty Hospital, Saint Luke’s Cancer Institute, MAWD Pathology Group, Kansas City Urology Care and more. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive care. The American College of Surgeons’ Commission on Cancer is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care.
Learn more about Saint Luke’s Cancer Institute at saintlukeskc.org. More information about the CoC can be found at facs.org.